Region:Asia
Author(s):Sunaiyna Varma
Product Code:KR1283
The report provides a comprehensive analysis of the potential of Oncology Device and Solution industry in India. The report covers an overview and genesis of the industry, market size in terms of revenue.
Its market segmentations include By Type, By Region, By Clinical Application, By Application, By End Users, By Test Type; growth enablers and drivers; challenges and bottlenecks; trends driving adoption trends; regulatory framework; end-user analysis, industry analysis, competitive landscape including competition scenario and market shares of major players. The report concludes with future market projections of each market segmentation and analyst recommendation’s.
According to Ken Research estimates India Oncology Devices and Solutions Market (Revenue) has grown at a CAGR of 18.2% from FY’17-22 supported by heightened manufacturing innovation and growing disease awareness. The rising medical devices industry is benefiting the growth of the oncology devices market.
By Clinical Application: In India, amongst all prevalent cancers, the five most common types are breast cancer, lung cancer, oral cancer, stomach cancer and cervical cancer. In India, every four minutes a woman is diagnosed with breast cancer.
By Test Type: Laboratory Cancer Diagnostic Tests like Bloods tests, urinanalysis, tumor markers, etc. account for around ~% of the total oncology tests performed in India. Other tests include tests like genetic tests, biopsies, etc.
India Oncology Devices and Solutions Market (Revenue) is expected to grow at a CAGR of 23.1% from FY’2022-2027 with the oncology devices and solutions market capacity to steadily expand, meeting the underserved and unserved demand
Longer-term investments in the public sector are expected to increase for the current private sector exclusive treatments
Next-Gen Oncology Devices and Solutions Market |
|
By Type |
By Devices By Solutions |
By Region |
North India West and Central India East and North East India South India |
By Clinical Application |
Cervical Cancer Blood Cancer Prostate Cancer Liver Cancer |
Segmentation of India Next-Gen Oncology Devices |
|
By Test Type |
Laboratory Tests Imaging Tests Others |
Oncology Solutions
Oncology Devices Companies
1.1 Executive Summary: India Next-Generation Oncology Devices and Solutions Market
2.1 India Country Overview
2.2 India Population Overview
2.3 Healthcare Budget in India
2.4 Healthcare Infrastructure in India
2.5 Major NABL accredited Labs in India
2.6 Cancer Prevalence in India
2.7 India Medical Tourism, FY’22
3.1 Industry Cycle of India Oncology Next-Gen Devices and Solutions Market
3.2 Overview of India Oncology Next-Gen Devices and Solutions Market
3.3 Trends in India Oncology Next-Gen Devices and Solutions Market
3.4 Growing Oncology Diagnostic and Treatment Techniques in India
4.1 Market Size on the basis of Revenue, FY’17-FY’21
4.2 India Next-Gen Oncology Devices and Solutions Market Segmentation by Type, FY’22
4.3 India Next-Gen Oncology Devices and Solutions Market Segmentation by Region, FY’22
4.4 India Next-Gen Oncology Devices and Solutions Market Segmentation by Clinical Application, FY’22
5.1 Different Fields of Oncology
5.2 Ecosystem of India Oncology Devices Market
5.3 Value Chain Analysis in India Oncology Devices Market
5.4 Market Sizing Analysis of India Next-Gen Oncology Devices Market, FY’17-FY’22
5.5 Market Segmentation of India Next-Gen Oncology Devices by Technology, FY’22
5.6 Market Segmentation of India Next-Gen Oncology Devices by Application, FY’22
5.7 Market Segmentation of India Next-Gen Oncology Devices by End Users, FY’22
5.8 Competition Analysis: Market Share of major Oncology Devices Players in India
5.9 Cross Comparison of major Oncology Devices Players in India
5.10 India Next-Gen Oncology Devices Market Future Sizing, FY’22-FY’27F
5.11 Market Segmentation of India Next-Gen Oncology Devices by Technology, FY’27F
5.12 Market Segmentation of India Next-Gen Oncology Devices by Application, FY’27F
5.13 Market Segmentation of India Next-Gen Oncology Devices by End Users, FY’27F
6.1 Cancer Patient Journey and Types of tests
6.2 Market Sizing Analysis of India Oncology Solutions Market, FY’17-FY’22
6.3 Market Segmentation of India Oncology Solutions Market by Test Type, FY’22
6.4 India Oncology Solutions Market Future Sizing, FY’22-FY’27F
6.5 Market Segmentation of India Oncology Solutions Market by Test Type, FY’27F
7.1 Target customers by type of end users
8.1 Regulatory Landscape for Next-Gen Oncology Devices in India
8.2 SWOT Analysis of the Indian Next-Gen Oncology Devices and Solutions Market
8.3 Major Growth Drivers in India Next-Gen Oncology Devices and Solutions Market
8.4 Challenges & Bottle Necks in India Oncology Devices and Solutions Market
10.1 Market Size on the basis of Revenue, FY’22-FY’27
10.2 India Next-Gen Oncology Devices and Solutions market segmentation by Region, FY’2027
10.3 India Next-Gen Oncology Devices and Solutions market segmentation by Type, FY’2027
10.4 India Next-Gen Oncology Devices and Solutions market segmentation by Clinical
10.5 Application, FY’2027
11.1 Way Forward: Future Trends and Technologies to leverage in Strategies: Action Plan
12.1 Market Definitions and Assumptions
12.2 Abbreviations
12.3 Market Sizing Approach
12.4 Consolidated Research Approach
12.5 Research Limitations and Future Conclusion
Ecosystem creation for all the major entities and referring to multiple secondary and proprietary databases to perform desk research around market to collate industry level information.
Analysts have adopted a Bottom-to-Top approach to build the market size on the basis of annual number of devices sold and tests done. These data points were then multiplied by their respective average costs to obtain Next-Gen Oncology Devices and Solutions market size.
Building market hypothesis and conducting CATIs with industry exerts belonging to different companies to validate statistics and seek operational and financial information from company representatives.
Our team will approach multiple finance providing channels and understand nature of product segments and sales, consumer preference and other parameters, which will support us validate statistics derived through bottom to top approach from car finance providers.
The India Next-Gen Oncology Device and Solution Market is covered from FY’2017–FY’2027 in this report, including a forecast for FY’2023-FY’2027.
The India Next-Gen Oncology Device and Solution Market is expected to witness a CAGR of ~23% over the next four years.
Increasing Prevalence of Oncology Population, Emerging Technologies in Oncology Testing and Treatment and Increasing Disease Awareness.
The Laboratory test type segment held the largest share of the India Next-Gen Oncology Device and Solution Market in FY’2022.
Fortis, Apollo, Max healthcare, AIIMS, Elekta, Accuray, IBA are the Key Players in the India Next-Gen Oncology Device and Solution Market.
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.